Within other types of cancer (e.g. prostate and breast cancer), the roles of IGFBP-3 and IGFBP-2 have been more thoroughly described, and demonstrated to convey both inhibitory and stimulating effects on tumor progression, depending on the tissue and type of cancer [12]. The gene discussed is IGFBP2; the disease is cancer.